Triple-negative breast cancer (TNBC) accounts for 15% to 20% of breast cancer cases and
is characterized by the absence of estrogen, progesterone, and human epidermal growth …

Breast cancer accounts for 25% of all types of cancer in women, and triple negative breast
cancer (TNBC) comprises around 15~ 20% of breast cancers. Conventional chemotherapy …

Triple-negative breast cancer (TNBC) is characterised by poor outcomes and a historical
lack of targeted therapies. Dysregulation of signalling through the phosphoinositide 3 (PI3) …

Various studies have evaluated the significance of PTEN (phosphatase and tensin homolog
deleted from chromosome 10) expression in breast cancer, but their results remain …

Recent studies demonstrated that long noncoding RNAs (lncRNAs) have a critical role in the
regulation of cancer progression and metastasis. However, little is known about the …

Ovarian cancer (OC) is one of the most common gynecologic cancer, which has the worst
prognosis and highest mortality rate. The lack of curative treatment and the high relapse …

Background: Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors
characterized by their aggressive nature and poor associated survival. MicroRNAs (miRs) …

Breast cancer is the most commonly occurring malignancy and the leading cause of cancer-
related death in women. Triple-negative breast cancer (TNBC) is the most aggressive …

Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by
the absence of three hallmark receptors: human epidermal growth factor receptor 2 …

Triple-negative breast cancer (TNBC) is a heterogeneous disease enriched for mutations in
PTEN and dysregulation of innate immune signaling. Here, we demonstrate that Rab7, a …